Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 6—June 2004
Dispatch

Antibacterial Resistance, Wayampis Amerindians, French Guyana

Karine Grenet*, Didier Guillemot†, Vincent Jarlier‡, Brigitte Moreau§, Stéphane Dubourdieu*, Laurent Boyer*, Laurence Armand-Lefevre*, Pierre Bau*, and Antoine Andremont*Comments to Author 
Author affiliations: *Assistance Publique-Hôpitaux de Paris, Paris, France; †Pharmaco-Épidémiologie Institut Pasteur, Paris, France; ‡Groupe Hospitalier Pitié-Salpêtrière, Paris, France; §Centre Hospitalier de Cayenne, French Guyana

Main Article

Table 2

Prevalence of carriage of gram-negative bacteria resistant to various antibacterial agents in the predominant and the subdominant fecal flora of the 93 study participantsa

Antibacterial agent Predominant florab
Subdominant flora
Escherichia coli (%) Klebsiella sp. (%) Enterobacter sp. (%) Other (%) Any (%) Lactose positive (%) Lactose negative (%) Any (%)
Ampicillin
51 (55)
19 (21)
5 (5)
2 (2)
77 (83)
89 (96)
31 (33)
93 (100)
Ceftazidime
0
0
0
0
0
3c (4)
11d (12)
14 (15)
Nalidixic acid
0
0
0
0
0
7e (8)
0
7 (8)
Pefloxacine
0
0
0
0
0
ND
ND
ND
Streptomycin
42 (45)
2 (2)
0
0
44 (47)
83 (90)
19 (21)
86 (93)
Kanamycin
5 (5)
0
0
0
5 (5)
45 (49)
4 (5)
47 (51)
Tetracycline
59 (63)
14 (15)
0
2 (2)
75 (81)
86 (93)
25 (27)
86 (93)
Cotrimoxazole
27 (29)
0
0
0
27 (29)
ND
ND
ND
Chloramphenicol 22 (24) 0 0 0 22 (24) 48 (52) 27 (29) 60 (67)

aAccounting for 23.9% (93 of 388) of the global population of the villages studied and not significantly different from it for male/female ratio or age distribution.
bBacteria with intermediate susceptibility were categorized as resistant.
cExtended spectrum β-lactamase E. coli.
dAcinetobacter baumanni: 9 (all with the same susceptibility pattern including susceptibility to ureidopenicillins, third generation cephalosporins, aminoglycosides, and quinolones) and Ochrobactrum spp. (identified by 16s RNA genes sequencing): 2.
eE. coli.

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external